These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35961024)
1. Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis. Inthavong H; Vanarsa K; Castillo J; Hicks MJ; Mohan C; Wenderfer SE Rheumatology (Oxford); 2023 Mar; 62(3):1335-1342. PubMed ID: 35961024 [TBL] [Abstract][Full Text] [Related]
2. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus. Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C Front Immunol; 2022; 13():885307. PubMed ID: 35720325 [TBL] [Abstract][Full Text] [Related]
3. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C Front Immunol; 2020; 11():671. PubMed ID: 32351512 [TBL] [Abstract][Full Text] [Related]
8. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis. Gupta R; Yadav A; Aggarwal A Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146 [TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium. Soliman SA; Haque A; Mason S; Greenbaum LA; Hicks MJ; Mohan C; Wenderfer SE Lupus; 2021 Aug; 30(9):1394-1404. PubMed ID: 33990158 [TBL] [Abstract][Full Text] [Related]
11. Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis. Wu T; Du Y; Han J; Singh S; Xie C; Guo Y; Zhou XJ; Ahn C; Saxena R; Mohan C Mol Cell Proteomics; 2013 May; 12(5):1170-9. PubMed ID: 23345539 [TBL] [Abstract][Full Text] [Related]
12. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis. Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762 [TBL] [Abstract][Full Text] [Related]
13. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up. Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020 [TBL] [Abstract][Full Text] [Related]
14. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913 [TBL] [Abstract][Full Text] [Related]
15. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775 [TBL] [Abstract][Full Text] [Related]
16. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
17. Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis. Huang YJ; Lin CH; Yang HY; Luo SF; Kuo CF Front Immunol; 2022; 13():935700. PubMed ID: 35911758 [TBL] [Abstract][Full Text] [Related]
18. [Feasibility of SLEDAI-2000 and BILAG-2004 scoring systems for assessing renal disease activity in children with lupus nephritis]. Zhou JQ; Jiang H Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):775-9. PubMed ID: 23092572 [TBL] [Abstract][Full Text] [Related]
19. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations. Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043 [TBL] [Abstract][Full Text] [Related]